期刊文献+

结直肠癌中pERK1/2和pAKT表达模式的临床病理意义以及预测预后的价值

The pattern of expression of pERK1/2 and pAKT is association with the progression of colorectal cancer but not with the prognosis
下载PDF
导出
摘要 目的探讨磷酸化蛋白pERK1/2、pAKT在结直肠癌中表达的意义以及它们用于预测预后的价值。方法运用免疫组化法检测84例结直肠癌手术标本、癌旁正常黏膜pERK1/2、pAKT表达模式,13例腹部创伤手术患者的正常结直肠黏膜做为对照。分析pERK1/2、pAKT表达模式与临床病理特征以及生存预后的关系。结果 pERK1/2、pAKT表达率从癌灶(65.5%、58.3%)到癌旁(45.2%、44.0%)和对照组(30.8%、15.4%)依次降低,P<0.05;它们与肿瘤的大小、浸润深度、分化程度、T和N分期显著正相关;pERK1/2和pAKT双阳性表达病例、单阳病例、双阴病例的5年生存率和中位生存时间在趋势上依次升高,但差异无统计学意义,P>0.05。结论 ERK1/2、pAKT异常激活是结直肠癌的一个特征变化,二者磷酸化表达水平上调与肿瘤进展、侵袭性增强相关,但是目前的数据尚不支持pERK1/2、pAKT可以作为预测预后的独立因子。 Objective To investigate whether the expressions of phosphorylated proteins,pERK1/2 and pAKT are associated with the clinic pathologic features of colorectal cancer (CRC) and prognosis.Methods Immunostainning of pERK1/2 and pAKT was emplored to decete the paraffin slides derived from 84 samples of CRC and normal mucosa adjacent to the cancer,and 13 samples of abdominal injury people' normal colorectal mucosa that were considered as control group.Spearman correlation anlysis and life table method were conducted to explore if the two phosphorylated proteins expressions were associated with the clinic pathologic features and prognosis.Results The expressions of pERK1/2 and pAKT decreased gradually in the cohort of from CRC (65.5%,58.3%) to normal mucosa (45.2%,44.0%) and control (30.8%,15.4%) (P <0.05).Moreover,the expression of pERK1/2 and pAKT were significantly correlated with the tumor size,the depth of invasion,the differentiation and T/N stage.Although the cases of pERK1/2 and pAKT double stained displayed lower 5-year survival rate and shorter median survival time in trend by comparison with those cases of single stained or double negative stained,there were no significant differences (P >0.05).Conclusion The aberrant activations of ERK1/2 and AKT were considered as a character of CRC,and the up-regulations of them at phosphorylated levels were involved in the tumor progression and the enhanced invasive potential; however,the current data failed to support the hypothesis that the both of them were treated as independent prognostic factors for CRC.
出处 《结直肠肛门外科》 2013年第5期283-286,共4页 Journal of Colorectal & Anal Surgery
关键词 结直肠癌 pERK1 2 PAKT 预后 Colorectal cancer pERK1/2 pAKT Prognosis
  • 相关文献

参考文献10

  • 1Balmanno K, Cook SJ. Tumour cell survival signalling by the ERK1/2 pathway [J]. Cell Death Differ, 2009, 16(3) : 368-377.
  • 2Datta SR, Brunet A, Greenberg ME. Cellular surviv- al:a play in three Akts [J]. Genes Dev, 1999, 13 (22) :2905-2927.
  • 3Amsterdam A, Shezen E, Raanan C, et al. Two initi- ation sites of early detection of colon cancer, revealed by localization of pERK1/2 in the nuclei or in aggre- gates at the perinuclear region of tumor cells [J]. Int J Oncol, 2012, 40(3):782-788.
  • 4Henderson-Jackson EB, Helm J, Ghayouri M, et al. Correlation between Mcl-1 and pAKT protein expres- sion in coloreetal cancer [J]. Int J Clin Exp Pathol, 2010, 3(8) :768-774.
  • 5Baba Y, Nosho K, Shima K, et al. Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers[J]. Cancer, 2011, 117(7):1399-1408.
  • 6齐建康,黄晓丽,蒙张敏,甘华田,伏代刚.结肠癌组织中PTEN蛋白表达与PI3K/AKT信号通路的关系[J].四川大学学报(医学版),2009,40(4):644-646. 被引量:11
  • 7Deng X, Ruvolo P, Carr B, et al. Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases[J]. Proc Natl Acad Sci USA, 2000, 97 (4) :1578-1583.
  • 8Jazirehi AR, Vega MI, Chatterjee D, et al. Inhibition of the Raf-MEK1/2-ERK1/2 Signaling Pathway, Bcl- xL Down-Regulation, and Chemosensitization of Nora Hodgkin' s Lymphoma B Cells by Rituximab [J]. Cancer Res, 2004, 64(19) :7117 -7126.
  • 9Ramljak D, Coticchia CM, Nishanian TG, et al. Epi- dermal growth factor inhibition of c-Myc-mediated ap- optosis through Akt and Erk involves Bcl-xL upregula- tion in mammary epithelial cells [J].Exp Cell Res, 2003, 287(2) :397-410.
  • 10Schmitz KJ, Otterbaeh F, Callies R, et al. Prognostic relevance of activated Akt kinase in node-negative breast cancer: a clinicopathologieal study of 99 cases [J]. ModPathol, 2004, 17(1) :15-21.

二级参考文献12

  • 1周晓东,于皆平,于红刚,罗和生,吕农华,朱萱.蛋白激酶B在胃癌中的表达及其生物学意义[J].中华消化杂志,2005,25(7):401-405. 被引量:21
  • 2刘恩宇,易继林,宋炜,周旭,李兴睿,陈晚平.肝细胞癌组织中抑癌基因PTEN与pAkt的表达及其相关性研究[J].中华肿瘤防治杂志,2006,13(1):51-54. 被引量:12
  • 3Iwao K,Shuho S,Yoshiko M,et al.Significance of AKT phosphorylation on tumor growth and vascular endothelial growth factor expression in human gastric carcinoma.Pathobiology,2006;73(1):8-17.
  • 4Li L,Ross AH.Why is PTEN an important tumor suppressor? J Cell Biochem,2007;102(6):1368-1372.
  • 5Depowski PL,Rosenthal SI,Ross JS.Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer.Mod Pathol,2001;14(7):672-676.
  • 6Koksal IT,Yasar D,Dirice E,et al.Differential PTEN protein expression profiles in superficial versus invasive bladder cancers.Urology,2005;75(2):102-106.
  • 7Kaiser GC,Yan F,Polk DB,et al.Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kB activation in mouse coloncytes.Gastroenterology,1999;116(6):602-609.
  • 8Sambrook J,Fritsch EF,Maniatis T.Molecular coloning:a laboratory manual 2 nd ed.Cold Spring Havbor:Cold Spring Harbor Laboratory Press,1989:1860-1863.
  • 9Hayes MP,Wang H,Espinal-Witter R,et al.PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia.Clin Cancer Res,2006;12(20):5932-5936.
  • 10Wu H,Goel V,Haluska FG,et al.PTEN signaling pathways in Melanoma.Oncogene,2003;22(20):3113-3122.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部